Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

367
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
367
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

4.8K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
4.8K
Binomial Probability Distribution01:15

Binomial Probability Distribution

12.6K
A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
12.6K
Hazard Rate01:11

Hazard Rate

210
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
210
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

691
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
691
Statistical Hypothesis Testing01:16

Statistical Hypothesis Testing

2.8K
Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Mortality-weighted severe maternal morbidity: a novel approach to assessing maternal health outcomes.

BMC pregnancy and childbirth·2025
Same author

Pair-Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study.

Obesity (Silver Spring, Md.)·2025
Same author

Bayesian network meta-regression for aggregate ordinal outcomes with imprecise categories.

Journal of biopharmaceutical statistics·2025

Related Experiment Video

Updated: Oct 8, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Bayesian multivariate probability of success using historical data with type I error rate control.

Ethan M Alt1, Matthew A Psioda2, Joseph G Ibrahim2

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.

Biostatistics (Oxford, England)
|January 4, 2022
PubMed
Summary

This study introduces a Bayesian approach for clinical trials with multiple outcomes, offering better power and sample size determination than traditional frequentist methods for multiplicity problems.

Keywords:
Average probability of successMultiplicitySeemingly unrelated regression

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Oct 8, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methodology

Background:

  • Clinical trials frequently involve multiple outcomes, leading to multiplicity issues.
  • Frequentist methods for multiplicity are often conservative and complicate sample size determination.
  • Existing methods struggle to balance type I error control with statistical power.

Purpose of the Study:

  • To introduce a Bayesian methodology for multiple testing in clinical trials.
  • To address the challenges of multiplicity and sample size determination with multiple endpoints.
  • To develop a more powerful and robust approach compared to traditional frequentist methods.

Main Methods:

  • A Bayesian methodology for multiple testing is proposed, ensuring asymptotic type I error control.
  • A seemingly unrelated regression model is used to account for correlations between clinical outcomes.
  • A multivariate probability of success metric is developed for sample size calculations.

Main Results:

  • The Bayesian approach demonstrates higher statistical power than Holm's method and Bonferroni correction.
  • The methodology effectively models correlations between multiple outcomes for joint inference.
  • The multivariate probability of success provides a robust method for sample size determination.

Conclusions:

  • The proposed Bayesian methodology offers an effective solution for multiplicity problems in clinical trials.
  • This approach enhances statistical power and improves sample size planning for studies with multiple outcomes.
  • Bayesian methods provide a flexible and powerful alternative for complex clinical trial designs.